ArticleThe Plant journal : for cell and molecular biology2025
Recovery of RNA-dependent RNA polymerase 6 gene-knockout phenotypes in Nicotiana benthamiana via in vivo generation of inverted repeat construct of the trans-acting short interference RNA3 sequence.
Article in The Plant journal : for cell and molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genetic Divergence and Functional Significance of Bioactive Compounds in Rice and Barley: Implications for Biofortification and Human Health.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Pharmaceutical recombinant proteins are widely produced using plants; however, several challenges such as low productivity limit their application. To overcome these problems, RNA-dependent RNA polymerase 6-knockout Nicotiana benthamiana plants (rdr6 plants) were previously produced for the mass production of recombinant proteins. These rdr6 plants produced higher amounts of recombinant proteins than wild-type plants, but their practical use for recombinant protein production is limited by their sterility and small leaf size. As an essential component of the microRNA 390-trans-acting short interference RNA3-auxin response factor (miR390-TAS3-ARF) pathway, rdr6 modulates leaf morphology, flower architecture, and embryo development. In fact, the expression levels of ARF3 and 4 genes differed in leaves, flowers, and buds of wild-type and rdr6 plants. Therefore, a dysfunctional miR390-TAS3-ARF pathway might be responsible for the sterility and small leaf size of the rdr6 plants. Herein, to overcome the disadvantages of rdr6 plants while maintaining the high productivity of recombinant proteins, the miR390-TAS3-ARF pathway was reconstructed. Transgenic rdr6 plants expressing the inverted repeat constructs of the TAS3 sequence of N. benthamiana were successfully produced (TAS3i plants). These plants produced seeds and large leaves, like the wild-type plants, while maintaining a high productivity of recombinant proteins, like the rdr6 plants. Thus, the TAS3i plants can be considered useful for producing recombinant proteins. This is the first report that the miR390-TAS3-ARF pathway can function in plants in the absence of RDR6.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.